Commercialization And Logistics
-
Perfusion: Hardware Needs
6/16/2025
In this video, we will discuss cell retention mechanisms, pumps, and intensification challenges in the perfusion process.
-
Tailoring Purification Solutions To Address Customer Challenges
5/21/2025
Developing purification products for novel biotherapeutics requires close customer collaboration to ensure the tools do the job. Hear how these partnerships drive targeted innovation.
-
Enabling Assurance Of Supply Through Evolving Bioprocessing Needs
11/12/2025
This featured event at the Gibco cell culture media 60th-anniversary in Grand Island, New York spotlights proactive strategies used by Thermo Fisher Scientific to decrease risk, ensure quality and meet customers raw material needs worldwide.
-
CTS DynaCellect Cinematic Overview
6/2/2025
Achieve high cell purity and recovery with an automated, closed magnetic separation system. Learn how this technology helps increase robustness, minimize failures, and streamline cell therapy manufacturing.
-
Knowledge Culture: Downstream Innovation
6/2/2025
In this workshop, you’ll learn about various solutions, from cell isolation to cell expansion, that can support autologous and allogeneic cell therapy process needs, digital automation, and mycoplasma testing.
-
CTS DynaCellect Magnetic Separation System Cell Isolation
5/22/2025
Ready to achieve high-purity results in your cell therapy manufacturing? This step-by-step guide demonstrates the complete setup and installation for your automated magnetic cell isolation system and kit.
-
Innovations In Mycoplasma And Sterility Testing For Biopharma
5/22/2025
In this webinar, our expert speakers will discuss the types of analytical testing that can be effectively employed in the early stages of therapeutic development and subsequently scaled to meet production challenges.
-
AAV Downstream Challenges: Expert Insights
5/22/2025
Gain expert insight into the complexities of AAV purification to learn how industry leaders tackle downstream challenges, optimize workflows, and drive innovation in scalable, efficient gene therapy manufacturing solutions.
-
Thermo Fisher Scientific Customer Experience Center Overview
5/19/2025
Explore cutting-edge single-use technologies with hands-on training at the Customer Experience Center, which is an immersive hub for innovation, learning, and bioprocessing expertise.
-
Manufacturing Hurdles With Viral Vectors
11/13/2023
With a wide range of viral vector-based drugs already approved, viral vectors are expected to remain the primary delivery mechanism for the foreseeable future. However, as the demand for viral vectors increases, addressing the challenges related to their manufacture and scale-up is critical. In this segment, Dave Maheu, VP, Head of Process & Analytical Development at Candel Therapeutics and Curran Simpson, Chief Operating Officer at REGENXBIO share what they consider to be the most difficult challenges in vector development and manufacturing currently.